Gene · 6239
Papers2,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,585
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma. | J Dent Sci | 2022 | 35028061 | PubTator, text mining | PubMed |
| Genetic risk of hyperuricemia in hypertensive patients associated with antihypertensive drug therapy: A longitudinal study. | Clin Genet | 2022 | 35023146 | PubTator, text mining | PubMed |
| Ancestry- and sex-specific effects underlying inguinal hernia susceptibility identified in a multiethnic genome-wide association study meta-analysis. | Hum Mol Genet | 2022 | 35022708 | PubTator, text mining | PubMed |
| High mobility group box protein 1 and white matter injury following traumatic brain injury: perspectives on mechanisms and therapeutic strategies. | Neural Regen Res | 2022 | 35017426 | PubTator, text mining | PubMed |
| Glacial and postglacial sedimentary infill in Slovakian High Tatra Mts. lakes: Acoustic survey and lithological data. | Data Brief | 2022 | 34993282 | PubTator, text mining | PubMed |
| TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration. | Nat Neurosci | 2022 | 34916658 | PubTator, text mining | PubMed |
| Ras signaling and RREB1 are required for the dissociation of medial edge epithelial cells in murine palatogenesis. | Dis Model Mech | 2022 | 34897389 | PubTator, text mining | PubMed |
| Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA. | Rheumatology (Oxford) | 2022 | 34888651 | PubTator, text mining | PubMed |
| Novel insights into the BAP1-inactivated melanocytic tumor. | Mod Pathol | 2022 | 34857909 | PubTator, text mining | PubMed |
| Mitochondrial transcription factor B1 promotes the progression of hepatocellular carcinoma via enhancing aerobic glycolysis. | J Cell Commun Signal | 2022 | 34825289 | PubTator, text mining | PubMed |
| Drug-eluting intraocular lens with sustained bromfenac release for conquering posterior capsular opacification. | Bioact Mater | 2022 | 34820575 | PubTator, text mining | PubMed |
| Genomic comparisons between hepatocarcinogenic and non-hepatocarcinogenic organophosphate insecticides in the mouse liver. | Toxicology | 2022 | 34813904 | PubTator, text mining | PubMed |
| Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets. | Biomed Pharmacother | 2022 | 34801852 | PubTator, text mining | PubMed |
| Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation. | Mol Omics | 2022 | 34709266 | PubTator, text mining | PubMed |
| An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity. | Cell Chem Biol | 2022 | 34672954 | PubTator, text mining | PubMed |
| Recent advances in the detection of interferon-gamma as a TB biomarker. | Anal Bioanal Chem | 2022 | 34665279 | PubTator, text mining | PubMed |
| An Unusual Case of Desmoplastic Melanoma With Monster Cells Imitating an Atypical Fibroxanthoma. | Int J Surg Pathol | 2022 | 34541940 | PubTator, text mining | PubMed |
| Fluorescent in situ hybridization (FISH): A useful diagnostic tool for childhood conjunctival melanoma. | Eur J Ophthalmol | 2022 | 34240653 | PubTator, text mining | PubMed |
| Epigenome editing of the CFTR-locus for treatment of cystic fibrosis. | J Cyst Fibros | 2022 | 34049825 | PubTator, text mining | PubMed |
| Novel pathomechanism for spontaneous bacterial peritonitis: disruption of cell junctions by cellular and bacterial proteases. | Gut | 2022 | 33707230 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6239/papers?page=29